192 related articles for article (PubMed ID: 35170221)
1. A novel nonsense variant in TPM4 caused dominant macrothrombocytopenia, mild bleeding tendency and disrupted cytoskeleton remodeling.
Marín-Quílez A; Vuelta E; Díaz-Ajenjo L; Fernández-Infante C; García-Tuñón I; Benito R; Palma-Barqueros V; Hernández-Rivas JM; González-Porras JR; Rivera J; Bastida JM
J Thromb Haemost; 2022 May; 20(5):1248-1255. PubMed ID: 35170221
[TBL] [Abstract][Full Text] [Related]
2. Rare missense variants in Tropomyosin-4 (TPM4) are associated with platelet dysfunction, cytoskeletal defects, and excessive bleeding.
Stapley RJ; Poulter NS; Khan AO; Smith CW; Bignell P; Fratter C; Lester W; Lowe G; Morgan NV;
J Thromb Haemost; 2022 Feb; 20(2):478-485. PubMed ID: 34758189
[TBL] [Abstract][Full Text] [Related]
3. Mutations in tropomyosin 4 underlie a rare form of human macrothrombocytopenia.
Pleines I; Woods J; Chappaz S; Kew V; Foad N; Ballester-Beltrán J; Aurbach K; Lincetto C; Lane RM; Schevzov G; Alexander WS; Hilton DJ; Astle WJ; Downes K; Nurden P; Westbury SK; Mumford AD; Obaji SG; Collins PW; Delerue F; Ittner LM; Bryce NS; Holliday M; Lucas CA; Hardeman EC; Ouwehand WH; Gunning PW; Turro E; Tijssen MR; Kile BT
J Clin Invest; 2017 Mar; 127(3):814-829. PubMed ID: 28134622
[TBL] [Abstract][Full Text] [Related]
4. Novel variants in GALE cause syndromic macrothrombocytopenia by disrupting glycosylation and thrombopoiesis.
Marín-Quílez A; Di Buduo CA; Díaz-Ajenjo L; Abbonante V; Vuelta E; Soprano PM; Miguel-García C; Santos-Mínguez S; Serramito-Gómez I; Ruiz-Sala P; Peñarrubia MJ; Pardal E; Hernández-Rivas JM; González-Porras JR; García-Tuñón I; Benito R; Rivera J; Balduini A; Bastida JM
Blood; 2023 Jan; 141(4):406-421. PubMed ID: 36395340
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the Platelet Phenotype Caused by a Germline RUNX1 Variant in a CRISPR/Cas9-Generated Murine Model.
Marín-Quílez A; García-Tuñón I; Fernández-Infante C; Hernández-Cano L; Palma-Barqueros V; Vuelta E; Sánchez-Martín M; González-Porras JR; Guerrero C; Benito R; Rivera J; Hernández-Rivas JM; Bastida JM
Thromb Haemost; 2021 Sep; 121(9):1193-1205. PubMed ID: 33626581
[No Abstract] [Full Text] [Related]
6. Novel SLFN14 mutation associated with macrothrombocytopenia in a patient with severe haemorrhagic syndrome.
Polokhov D; Fedorova D; Ignatova A; Ponomarenko E; Rashevskaya E; Martyanov A; Podoplelova N; Aleksenko M; Mersiyanova I; Seregina E; Poletaev A; Truchina E; Raykina E; Plyasunova S; Novichkova G; Zharkov P; Panteleev M
Orphanet J Rare Dis; 2023 Apr; 18(1):74. PubMed ID: 37041648
[TBL] [Abstract][Full Text] [Related]
7. Inherited thrombocytopenias: history, advances and perspectives.
Nurden AT; Nurden P
Haematologica; 2020 Aug; 105(8):2004-2019. PubMed ID: 32527953
[TBL] [Abstract][Full Text] [Related]
8. Deleterious mutation in the FYB gene is associated with congenital autosomal recessive small-platelet thrombocytopenia.
Levin C; Koren A; Pretorius E; Rosenberg N; Shenkman B; Hauschner H; Zalman L; Khayat M; Salama I; Elpeleg O; Shalev S
J Thromb Haemost; 2015 Jul; 13(7):1285-92. PubMed ID: 25876182
[TBL] [Abstract][Full Text] [Related]
9. Megakaryocyte modification of platelets in thrombocytopenia.
Roweth HG; Parvin S; Machlus KR
Curr Opin Hematol; 2018 Sep; 25(5):410-415. PubMed ID: 29985173
[TBL] [Abstract][Full Text] [Related]
10. SLFN14 mutations underlie thrombocytopenia with excessive bleeding and platelet secretion defects.
Fletcher SJ; Johnson B; Lowe GC; Bem D; Drake S; Lordkipanidzé M; Guiú IS; Dawood B; Rivera J; Simpson MA; Daly ME; Motwani J; Collins PW; Watson SP; Morgan NV;
J Clin Invest; 2015 Sep; 125(9):3600-5. PubMed ID: 26280575
[TBL] [Abstract][Full Text] [Related]
11. Germline variants in ETV6 underlie reduced platelet formation, platelet dysfunction and increased levels of circulating CD34+ progenitors.
Poggi M; Canault M; Favier M; Turro E; Saultier P; Ghalloussi D; Baccini V; Vidal L; Mezzapesa A; Chelghoum N; Mohand-Oumoussa B; Falaise C; Favier R; Ouwehand WH; Fiore M; Peiretti F; Morange PE; Saut N; Bernot D; Greinacher A; BioResource N; Nurden AT; Nurden P; Freson K; Trégouët DA; Raslova H; Alessi MC
Haematologica; 2017 Feb; 102(2):282-294. PubMed ID: 27663637
[TBL] [Abstract][Full Text] [Related]
12. Dominant inheritance of a novel integrin beta3 mutation associated with a hereditary macrothrombocytopenia and platelet dysfunction in two Italian families.
Gresele P; Falcinelli E; Giannini S; D'Adamo P; D'Eustacchio A; Corazzi T; Mezzasoma AM; Di Bari F; Guglielmini G; Cecchetti L; Noris P; Balduini CL; Savoia A
Haematologica; 2009 May; 94(5):663-9. PubMed ID: 19336737
[TBL] [Abstract][Full Text] [Related]
13. ACTN1-related thrombocytopenia: identification of novel families for phenotypic characterization.
Bottega R; Marconi C; Faleschini M; Baj G; Cagioni C; Pecci A; Pippucci T; Ramenghi U; Pardini S; Ngu L; Baronci C; Kunishima S; Balduini CL; Seri M; Savoia A; Noris P
Blood; 2015 Jan; 125(5):869-72. PubMed ID: 25361813
[TBL] [Abstract][Full Text] [Related]
14. Platelet dysfunction caused by a novel thromboxane A
Bugert P; Fischer L; Althaus K; Knöfler R; Bakchoul T
Platelets; 2020; 31(2):276-279. PubMed ID: 31389738
[TBL] [Abstract][Full Text] [Related]
15. Cytoskeletal perturbation leads to platelet dysfunction and thrombocytopenia in variant forms of Glanzmann thrombasthenia.
Bury L; Falcinelli E; Chiasserini D; Springer TA; Italiano JE; Gresele P
Haematologica; 2016 Jan; 101(1):46-56. PubMed ID: 26452979
[TBL] [Abstract][Full Text] [Related]
16. Inherited thrombocytopenias-recent advances in clinical and molecular aspects.
Balduini CL; Melazzini F; Pecci A
Platelets; 2017 Jan; 28(1):3-13. PubMed ID: 27161842
[TBL] [Abstract][Full Text] [Related]
17. An oligogenic case of severe neonatal thrombocytopenia and a purportedly benign variant in
Frenkel M; Hall A; Meyn MS; Diamond CA
Platelets; 2023 Dec; 34(1):2237592. PubMed ID: 37577973
[TBL] [Abstract][Full Text] [Related]
18. Whole exome sequencing identifies a mutation in thrombomodulin as the genetic cause of a suspected platelet disorder in a family with normal platelet function.
Maclachlan A; Dolan G; Grimley C; Watson SP; Morgan NV; On Behalf Of The Uk Gapp Study Group
Platelets; 2017 Sep; 28(6):611-613. PubMed ID: 28267383
[TBL] [Abstract][Full Text] [Related]
19. Molecular phenotype and bleeding risks of an inherited platelet disorder in a family with a RUNX1 frameshift mutation.
Badin MS; Iyer JK; Chong M; Graf L; Rivard GE; Waye JS; Paterson AD; Pare G; Hayward CPM
Haemophilia; 2017 May; 23(3):e204-e213. PubMed ID: 28181366
[TBL] [Abstract][Full Text] [Related]
20. Inherited Platelet Disorders: A Modern Approach to Evaluation and Treatment.
Lambert MP
Hematol Oncol Clin North Am; 2019 Jun; 33(3):471-487. PubMed ID: 31030814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
